申请人:Li Hui
                            
                            
                                公开号:US20120213795A1
                            
                            
                                公开(公告)日:2012-08-23
                            
                            The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases are therapeutically useful.
                            该发明涵盖了具有I式的化合物以及使用这些化合物在治疗调节JAK途径或抑制JAK激酶在治疗上有用的疾病的组合物和方法。